| |
---|
| Detailed Price Information Link |
BACTERIA | How to read the following data (Example) |
Name: | Ureibacillus massiliensis (Glazunova et al. 2006) Gupta and Patel 2020 |
Synonym(s): | Bacillus massiliensis Glazunova et al. 2006 |
DSM No.: | 27596, Type strain dsm-27596 dsm27596 dsm 27596 Ureibacillus massiliensis |
Strain designation: | 4400831 |
Other collection no. or WDCM no.: | KCTC 13178,CCUG 49529,CIP 108446 |
Isolated from: | cerebrospinal fluid, human |
Country: | France Marseille |
Date of sampling: | before 16.08.2013 |
Nagoya Protocol Restrictions: | France requires a benefit-sharing declaration for French genetic resources at the time of utilization, i.e., conducting research. France considers access to genetic resources when utilization begins and not when the initial collection of the material took place and applies to material both in-situ and ex-situ and users within and outside of France.
To comply with French law, you, the user need to make a Declaration regarding access to genetic resources and benefit-sharing arising from your non-commercial utilisation of genetic resources. The steps are the following:
1. File a declaration via the CERFA form n. 15786 (https://www.formulaires.service-public.fr/gf/getAnnexe.do?cerfaAnnexe=1&cerfaFormulaire=15786*02) or by electronic procedure (https://www.demarches-simplifiees.fr/commencer/apa-declaration-pmorale)
2. Await approval by the Ministry for the Ecological Transition, the competent national authority
3. Respond to any requests for more information from the competent national authority
4. Receive an acknowledgment of receipt by the competent national authority certifying the prior informed consent (PIC) and establishment of mutually agreed terms (MAT) regarding benefit-sharing. This procedure shall not exceed 2 months.
For more information about this topic please see the Access and Benefit-Sharing Clearing House: https://absch.cbd.int/en/countries/FR
For more information about the commercial use of this genetic resources please contact: justiziariat@dsmz.de |
History: | <- KCTC; KCTC 13178 |
Genbank accession numbers: | 16S rRNA gene: AY677116 whole genome shotgun sequence: JPVQ00000000 |
Cultivation conditions: | Medium 220 , 37°C
Complete DSMZ Media List |
Summary and additional information: | <- KCTC; KCTC 13178. Cerebrospinal fluid, human; France, Marseille. Type strain. Taxonomy/description (10484, 17184). Sequence accession no. 16S rRNA gene: AY677116, whole genome shotgun sequence: JPVQ00000000. (Medium 220, 37°C). |
Literature: | 10484, 17184 |
Risk group: | 1 (+) (classification according to German TRBA) |
Supplied as: | Delivery form | | Prices | | Freeze Dried | | 100,- € | Active culture on request | | 240,- € | DNA | | 150,- € | | Price Category for this culture: 1 |
Freight and handling charges will be added. See price list. |
Other cultures: | All DSMZ cultures of the species |
| Print data sheet |